AzTrials
AzTrials

Child BehaviorPhase 4PSTNCT02945072

Clinical Study of Behavior Problems in Children After Different Anesthesia Methods

A Phase 4 study testing TIVA and Sevoflurane in people with Child Behavior and Problem Behavior, run by University Children's Hospital, Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate long-lasting or later behavioral changes in children in the context of different anesthesia techniques (Inhalation anesthesia vs. TIVA) Read more about this study

Who is it for?
Ages 2 to 10 yearsHealthy volunteers can take part
Conditions the study is for
Child Behavior, Problem Behavior
What is being tested?
TIVA and Sevoflurane
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteSwitzerland
Study dates
22 Jan 2018to 4 Jun 2024
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • elective Operation
  • operation in general anesthesia in combination with regional anesthesia
  • Age 2-10 years
  • ASA classification 1 or 2 (without severe basic disease or disability)

Who cannot join

  • Lack of Consensus
  • general anesthesia during the last 3 months before or 4 weeks after the procedure
  • PONV prophylaxis with droperidol
  • severe known growth factor
  • mental pre-existing conditions and behavioral abnormalities
  • contraindications for one of the used study medications
  • insufficient regional anesthesia
  • secondary intervention within of the 4-week follow-up

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Dr. Philipp Buehler

    Zurich, 8032

Other trials in Switzerland

About this study

Official title: Postoperative Behavior in Children: A Comparison of Inhalation Anesthesia (Sevoflurane) Versus Total Intravenous Anesthesia (TIVA)

The aim of this study is to investigate long-lasting or later behavioral changes in children in the context of different anesthesia techniques (Inhalation anesthesia vs. TIVA)

Read the detailed description

The process of surgery and anaesthesia can be an extremely frightening and stressful event for a child, and is frequently followed by negative postoperative behavioural changes. This Event could be associated with poor postoperative outcome and long term behavior problems like anxiety, eating or sleeping disorders. The aim of this study is to investigate long-lasting or later behavioral changes in children in the context of different anesthesia techniques (Inhalation anesthesia vs. TIVA). After anesthesia initiation, anesthesia maintenance should be done with sevoflurane or Tiva. The effect of behavioral changes in children in the context of anesthesia techniques should be evaluate by post hospitalisation behavior and Strengths and Difficulties Questionnaire at first, second and fourth week. Early postoperative problems like postoperative nausea and vomiting, pain level, pain therapy and postoperative awareness should be evaluate too.

Being tested
TIVA, Sevoflurane
Keywords
Child Behavior, Problem Behavior, postoperative behaviour problems
Medical subject headings
Child Behavior, Problem Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TIVAProcedure or surgery

    TIVA is use to anesthesia maintenance after anesthesia induction (Propofol 10mg/kg/h, Remifentanil 0.2mcg/kg/min, dose adaptation as required for sufficient anesthesia)

  • SevofluraneProcedure or surgery

    Sevoflurane is use to anesthesia maintenance after anesthesia induction (target et 2 Vol% in 50-70% N2O, dose adaptation as required)

Study groups in NCT02945072
Study groupRoleWhat they receive
Sevoflurane groupActive comparatorgeneral anesthesia will be maintained with sevoflurane
Receives: Procedure: Sevoflurane
TIVA groupExperimentalgeneral anesthesia will be maintained with total intravenous anesthesia (propofol and remifentanyl)
Receives: Procedure: TIVA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score first week postoperatively

    Measured: first week postoperative

  2. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score second week postoperatively

    Measured: second week postoperative

  3. Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively

    child's PHBQ score fourth week postoperatively

    Measured: fourth week postoperative

  4. SDQ Questionnaire score postoperatively

    child's SDQ score first week postoperatively

    Measured: first week postoperative

  5. SDQ Questionnaire score postoperatively

    child's SDQ score second week postoperatively

    Measured: second week postoperative

  6. SDQ Questionnaire score postoperatively

    child's SDQ score fourth week postoperatively

    Measured: fourth week postoperative

Secondary outcomes (5)
  1. postoperative pain Level (by VAS)

    Visual Analog Scale for Pain (VAS Pain) were used to evaluate postoperative pain level

    Measured: in the first postoperative week (3 times a day)

  2. postoperative pain Level (by CHEOPS)

    CHEOPS (Children's Hospital of Eastern Ontario Pain Scale) were used to evaluate postoperative pain level

    Measured: in the first postoperative week (3 times a day)

  3. postoperative pain medication

    All pain medications are recorded during the first postoperative week.Nurses and parents recorded all substance and application times by questionnaire.

    Measured: in the first postoperative week

  4. Intraoperative awareness

    In order to record an intraoperative awareness, a semistructured interview is conducted with test questions.

    Measured: in the first and second postoperative day

  5. postoperative Nausea and vomiting

    Nausea and Vomiting are recognized in frequency and time using a questionnaire.

    Measured: in the first and second postoperative day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2016 (estimated)
  2. Study start22 Jan 2018
  3. Primary completion4 Jun 2024
  4. Study completion4 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Screening
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
500 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02945072
Sponsor's protocol ID
KEK-ZH-Nr. 2011-0009
Acronym
PST
Status last verified
Dec 2024
First submitted
13 Oct 2016
Last updated
19 Dec 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing TIVA and Sevoflurane in people with Child Behavior and Problem Behavior, run by University Children's Hospital, Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-Hospital Behaviour Questionnaire (PHBQ) score postoperatively (time frame: first week postoperative). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in